Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B6J3
Term | Name | Level | Count |
---|---|---|---|
GO:0006066 | alcohol metabolic process | 3 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016310 | phosphorylation | 5 | 11 |
GO:0019637 | organophosphate metabolic process | 3 | 11 |
GO:0019751 | polyol metabolic process | 4 | 11 |
GO:0032958 | inositol phosphate biosynthetic process | 5 | 11 |
GO:0043647 | inositol phosphate metabolic process | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044281 | small molecule metabolic process | 2 | 11 |
GO:0044283 | small molecule biosynthetic process | 3 | 11 |
GO:0046165 | alcohol biosynthetic process | 4 | 11 |
GO:0046173 | polyol biosynthetic process | 5 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090407 | organophosphate biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 11 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0016301 | kinase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity | 6 | 1 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 1 |
GO:0051765 | inositol tetrakisphosphate kinase activity | 5 | 1 |
GO:0051766 | inositol trisphosphate kinase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 308 | 312 | PF00656 | 0.197 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 33 | 35 | PF00675 | 0.470 |
CLV_NRD_NRD_1 | 351 | 353 | PF00675 | 0.282 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.482 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 252 | 256 | PF00082 | 0.284 |
DOC_CKS1_1 | 182 | 187 | PF01111 | 0.297 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 368 | 374 | PF00134 | 0.355 |
DOC_MAPK_MEF2A_6 | 167 | 175 | PF00069 | 0.357 |
DOC_PP1_RVXF_1 | 172 | 178 | PF00149 | 0.357 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.385 |
DOC_USP7_MATH_1 | 224 | 228 | PF00917 | 0.306 |
DOC_USP7_MATH_1 | 279 | 283 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 298 | 302 | PF00917 | 0.157 |
DOC_USP7_MATH_1 | 320 | 324 | PF00917 | 0.279 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.355 |
DOC_USP7_UBL2_3 | 194 | 198 | PF12436 | 0.234 |
DOC_USP7_UBL2_3 | 96 | 100 | PF12436 | 0.453 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.279 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.672 |
DOC_WW_Pin1_4 | 306 | 311 | PF00397 | 0.385 |
DOC_WW_Pin1_4 | 332 | 337 | PF00397 | 0.306 |
LIG_14-3-3_CanoR_1 | 30 | 34 | PF00244 | 0.460 |
LIG_14-3-3_CanoR_1 | 348 | 352 | PF00244 | 0.310 |
LIG_Actin_WH2_2 | 281 | 298 | PF00022 | 0.173 |
LIG_APCC_ABBA_1 | 104 | 109 | PF00400 | 0.501 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.680 |
LIG_BIR_III_4 | 11 | 15 | PF00653 | 0.458 |
LIG_BRCT_BRCA1_1 | 17 | 21 | PF00533 | 0.603 |
LIG_BRCT_BRCA1_1 | 85 | 89 | PF00533 | 0.384 |
LIG_FHA_1 | 336 | 342 | PF00498 | 0.402 |
LIG_FHA_2 | 182 | 188 | PF00498 | 0.279 |
LIG_FHA_2 | 262 | 268 | PF00498 | 0.409 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.413 |
LIG_FHA_2 | 36 | 42 | PF00498 | 0.319 |
LIG_Integrin_RGD_1 | 66 | 68 | PF01839 | 0.467 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.382 |
LIG_LIR_Gen_1 | 37 | 48 | PF02991 | 0.314 |
LIG_LIR_Gen_1 | 371 | 376 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 350 | 354 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 371 | 376 | PF02991 | 0.445 |
LIG_PDZ_Class_2 | 371 | 376 | PF00595 | 0.414 |
LIG_Pex14_1 | 40 | 44 | PF04695 | 0.427 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.452 |
LIG_Pex14_2 | 89 | 93 | PF04695 | 0.433 |
LIG_PTB_Apo_2 | 130 | 137 | PF02174 | 0.343 |
LIG_Rb_pABgroove_1 | 324 | 332 | PF01858 | 0.357 |
LIG_SH2_NCK_1 | 330 | 334 | PF00017 | 0.297 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.279 |
LIG_SH2_STAP1 | 330 | 334 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.315 |
LIG_SH2_STAT5 | 294 | 297 | PF00017 | 0.173 |
LIG_SH2_STAT5 | 373 | 376 | PF00017 | 0.409 |
LIG_SH2_STAT5 | 45 | 48 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.545 |
LIG_SH3_1 | 179 | 185 | PF00018 | 0.297 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.528 |
LIG_SH3_3 | 179 | 185 | PF00018 | 0.297 |
LIG_SUMO_SIM_anti_2 | 325 | 331 | PF11976 | 0.304 |
LIG_SUMO_SIM_par_1 | 325 | 331 | PF11976 | 0.286 |
LIG_UBA3_1 | 88 | 96 | PF00899 | 0.457 |
MOD_CDK_SPxxK_3 | 181 | 188 | PF00069 | 0.297 |
MOD_CK1_1 | 181 | 187 | PF00069 | 0.318 |
MOD_CK1_1 | 335 | 341 | PF00069 | 0.316 |
MOD_CK1_1 | 347 | 353 | PF00069 | 0.202 |
MOD_CK2_1 | 278 | 284 | PF00069 | 0.410 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.343 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.713 |
MOD_GlcNHglycan | 100 | 103 | PF01048 | 0.500 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.450 |
MOD_GlcNHglycan | 160 | 165 | PF01048 | 0.367 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.395 |
MOD_GlcNHglycan | 246 | 250 | PF01048 | 0.342 |
MOD_GlcNHglycan | 322 | 325 | PF01048 | 0.389 |
MOD_GSK3_1 | 218 | 225 | PF00069 | 0.342 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.392 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.534 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.298 |
MOD_NEK2_1 | 305 | 310 | PF00069 | 0.208 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.385 |
MOD_NEK2_2 | 29 | 34 | PF00069 | 0.505 |
MOD_PKA_1 | 34 | 40 | PF00069 | 0.333 |
MOD_PKA_2 | 201 | 207 | PF00069 | 0.360 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.470 |
MOD_PKA_2 | 347 | 353 | PF00069 | 0.322 |
MOD_Plk_1 | 357 | 363 | PF00069 | 0.339 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.421 |
MOD_Plk_4 | 322 | 328 | PF00069 | 0.249 |
MOD_Plk_4 | 369 | 375 | PF00069 | 0.350 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.314 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.279 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.666 |
MOD_ProDKin_1 | 306 | 312 | PF00069 | 0.385 |
MOD_ProDKin_1 | 332 | 338 | PF00069 | 0.306 |
MOD_SUMO_rev_2 | 181 | 190 | PF00179 | 0.357 |
TRG_ENDOCYTIC_2 | 373 | 376 | PF00928 | 0.409 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.294 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.488 |
TRG_ER_diArg_1 | 291 | 294 | PF00400 | 0.323 |
TRG_NES_CRM1_1 | 317 | 331 | PF08389 | 0.389 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKC0 | Leptomonas seymouri | 58% | 100% |
A0A1X0NEH0 | Trypanosomatidae | 32% | 100% |
A0A3S7X9M0 | Leishmania donovani | 87% | 100% |
A0A422N9V2 | Trypanosoma rangeli | 29% | 100% |
A4HMY1 | Leishmania braziliensis | 74% | 100% |
A4IBK5 | Leishmania infantum | 87% | 100% |
C9ZZ39 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9AFD8 | Leishmania major | 86% | 100% |
V5BTG0 | Trypanosoma cruzi | 32% | 100% |